Key result
Cavity closure using a Nitinol occluder device and transcatheter mitral valve implantation successfully managed severe postendocarditis mitral regurgitation in a high-risk surgical patient.
Why the study?
Mitral valve infective endocarditis involves a mitral annular abscess in approximately 15% of cases, for which surgery is standard, leaving an open question for nonsurgical candidates.
Population
One 80-year-old comorbid man with eradicated infective endocarditis and severe mitral regurgitation not eligible for surgery
Comparison
Mitral annulus cavity closure with a Nitinol occluder device and transcatheter mitral valve implantation
Design
Case report
Authors
Loading...
May offer a nonsurgical option for mitral annular abscess with regurgitation; hypothesis-generating and requires prospective validation.
Case Report (n=1)
This case demonstrates a novel transcatheter management approach to treat coexistent postendocarditis paravalvular and transvalvular mitral regurgitation in a patient with prohibitively high surgical risk.
Maznyczka et al. (2025) conducted a case report in Eradicated infective endocarditis with severe paravalvular and transvalvular mitral regurgitation (n=1). Cavity closure using a Nitinol occluder device and transcatheter mitral valve implantation was evaluated on Successful management. Cavity closure using a Nitinol occluder device and transcatheter mitral valve implantation successfully managed severe postendocarditis mitral regurgitation in a high-risk surgical patient.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: